Cargando…

Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes

The stepped wedge (SW) design is a type of unidirectional crossover design where cluster units switch from control to intervention condition at different prespecified time points. While a convention in study planning is to assume the cluster‐period sizes are identical, SW cluster randomized trials (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Zibo, Preisser, John S., Esserman, Denise, Turner, Elizabeth L., Rathouz, Paul J., Li, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Trial Design and Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292617/ https://www.ncbi.nlm.nih.gov/pubmed/34596912 http://dx.doi.org/10.1002/bimj.202100112

Ejemplares similares

A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials
por: Zhang, Ying, et al.
Publicado: (2022)

Marginal modeling of cluster-period means and intraclass correlations in stepped wedge designs with binary outcomes
por: Li, Fan, et al.
Publicado: (2021)

Unequal cluster sizes in stepped-wedge cluster randomised trials: a systematic review
por: Kristunas, Caroline, et al.
Publicado: (2017)

Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes
por: Ouyang, Yongdong, et al.
Publicado: (2020)

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS): Rationale and design of a cluster-randomized trial()()
por: Mills, Katherine T., et al.
Publicado: (2020)

An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome
por: Kristunas, Caroline A., et al.
Publicado: (2017)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs
por: Thompson, Jennifer A, et al.
Publicado: (2017)

Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples
por: Hemming, Karla, et al.
Publicado: (2017)

Rationale and design of a smartphone‐enabled, home‐based exercise program in patients with symptomatic peripheral arterial disease: The smart step randomized trial
por: Harzand, Arash, et al.
Publicado: (2020)

Relative efficiency of unequal cluster sizes in stepped wedge and other trial designs under longitudinal or cross‐sectional sampling
por: Girling, Alan J.
Publicado: (2018)

Implementation of a stepped wedge cluster randomized trial to evaluate a hospital mobility program
por: Hastings, Susan N., et al.
Publicado: (2020)

Sample size in cluster randomised trials with unequal clusters
por: Holloway, Ivana, et al.
Publicado: (2011)

Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events
por: Beyersmann, Jan, et al.
Publicado: (2021)

Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms
por: Copas, Andrew J., et al.
Publicado: (2021)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Generalizing the information content for stepped wedge designs: A marginal modeling approach
por: Li, Fan, et al.
Publicado: (2023)

Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)
por: Blanck, Oliver, et al.
Publicado: (2020)

Power and sample size calculation for stepped-wedge designs with discrete outcomes
por: Xia, Fan, et al.
Publicado: (2021)

Maximin design of cluster randomized trials with heterogeneous costs and variances
por: van Breukelen, Gerard J. P., et al.
Publicado: (2021)

Sample size determination for external pilot cluster randomised trials with binary feasibility outcomes: a tutorial
por: Hemming, K., et al.
Publicado: (2023)

The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials
por: Martin, James Thomas, et al.
Publicado: (2019)

Design and Rationale of the PRAGUE‐12 Trial: A Large, Prospective, Randomized, Multicenter Trial That Compares Cardiac Surgery With Left Atrial Surgical Ablation With Cardiac Surgery Without Ablation in Patients With Coronary and/or Valvular Heart Disease Plus Atrial Fibrillation
por: Straka, Zbyněk, et al.
Publicado: (2012)

Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): Rationale and design of a randomized controlled clinical trial()
por: Berry, Colin, et al.
Publicado: (2013)

Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: Rationale and design of the EARNEST study()
por: Moody, William E., et al.
Publicado: (2014)

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration
por: Pitcher, Alex, et al.
Publicado: (2015)

Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST‐Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease
por: Ripley, David P., et al.
Publicado: (2015)

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC‐ONC Study—A Single‐Center, Blinded, Randomized Controlled Trial
por: Chung, Robin, et al.
Publicado: (2016)

Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
por: Robinson, Jennifer G., et al.
Publicado: (2014)

Design and Rationale of the RE‐DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting
por: Cannon, Christopher P., et al.
Publicado: (2016)

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
por: Budoff, Matthew, et al.
Publicado: (2018)

Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2
por: Gilgen, Nicole, et al.
Publicado: (2018)

A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
por: Hayer, Manvir K., et al.
Publicado: (2017)

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease
por: Jiménez, David, et al.
Publicado: (2019)

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
por: McMurray, John J.V., et al.
Publicado: (2019)

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
por: Bavendiek, Udo, et al.
Publicado: (2019)

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
por: Bhatt, Deepak L., et al.
Publicado: (2019)

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study
por: Bunch, T. Jared, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_01aeqvhej31mqvlo3donpr6dfd